Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Vaccines

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 373 articles:
HTML format



Single Articles


    February 2024
  1. HOFMEYER KA, Ventura CL, Armstrong KL, Houchens CR, et al
    Project NexGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future.
    Clin Infect Dis. 2024 Feb 13:ciae073. doi: 10.1093.
    PubMed     Abstract available


  2. MCCONEGHY KW, Hur K, Dahabreh IJ, Jiang R, et al
    Early Mortality After the First Dose of Coronavirus Disease 2019 Vaccination: A Target Trial Emulation.
    Clin Infect Dis. 2024 Feb 6:ciad604. doi: 10.1093.
    PubMed     Abstract available


    January 2024
  3. GROV C, Zohra F, Mirzayi C, Stief M, et al
    Sexual and Gender Minorities' Vaccine Uptake and Behavioral Change in Response to the Mpox Outbreak in the United States: August 2022 Through November 2022.
    Clin Infect Dis. 2024 Jan 23:ciad793. doi: 10.1093.
    PubMed     Abstract available


  4. ISON MG, Papi A, Athan E, Feldman RG, et al
    Efficacy and safety of respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons.
    Clin Infect Dis. 2024 Jan 22:ciae010. doi: 10.1093.
    PubMed     Abstract available


  5. CHANDLER R, Montenegro N, Llorach C, Aguirre LN, et al
    Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted RSV Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomi
    Clin Infect Dis. 2024 Jan 8:ciad786. doi: 10.1093.
    PubMed     Abstract available


    December 2023
  6. TADESSE BT, Keddy KH, Rickett NY, Zhusupbekova A, et al
    Vaccination to Reduce Antimicrobial Resistance Burden-Data Gaps and Future Research.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available


  7. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    COVID-19 Vaccination: Safeguarding Against Post-COVID Cardiovascular Complications.
    Clin Infect Dis. 2023 Dec 6:ciad732. doi: 10.1093.
    PubMed    


  8. LEWIS NM, Zhu Y, Peltan ID, Gaglani M, et al
    Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
    Clin Infect Dis. 2023 Dec 5:ciad677. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  9. MOGHADAS SM, Shoukat A, Bawden CE, Langley JM, et al
    Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.
    Clin Infect Dis. 2023 Nov 30:ciad658. doi: 10.1093.
    PubMed     Abstract available


  10. LEE N, Nguyen L, Austin PC, Brown KA, et al
    Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults.
    Clin Infect Dis. 2023 Nov 24:ciad716. doi: 10.1093.
    PubMed     Abstract available


  11. ATHAN E, Baber J, Quan K, Scott RJ, et al
    Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Older Adults.
    Clin Infect Dis. 2023 Nov 22:ciad707. doi: 10.1093.
    PubMed     Abstract available


  12. ADAMS K, Weber ZA, Yang DH, Klein NP, et al
    Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season, VISION Network.
    Clin Infect Dis. 2023 Nov 16:ciad704. doi: 10.1093.
    PubMed     Abstract available


  13. LEE AW, Liu K, Lhomme E, Blie J, et al
    Immunogenicity and vaccine shedding after 1 or 2 doses of rVZVDeltaG-ZEBOV-GP Ebola vaccine (ERVEBO(R)): Results from a phase 2, randomized, placebo-controlled trial in children and adults.
    Clin Infect Dis. 2023 Nov 15:ciad693. doi: 10.1093.
    PubMed     Abstract available


  14. TIPPETT A, Ess G, Hussaini L, Reese O, et al
    Influenza Vaccine Effectiveness Pre-pandemic among Adults Hospitalized with Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and Older Adults.
    Clin Infect Dis. 2023 Nov 8:ciad679. doi: 10.1093.
    PubMed     Abstract available


    October 2023
  15. FONTAN-VELA M, Hernando V, Olmedo C, Coma E, et al
    Effectiveness of MVA-BN vaccination in a population at high-risk of mpox: a Spanish cohort study.
    Clin Infect Dis. 2023 Oct 21:ciad645. doi: 10.1093.
    PubMed     Abstract available


  16. CARAZO S, Guay CA, Skowronski DM, Amini R, et al
    Influenza hospitalization burden by subtype, age, comorbidity and vaccination status: 2012/13 to 2018/19 seasons, Quebec, Canada.
    Clin Infect Dis. 2023 Oct 11:ciad627. doi: 10.1093.
    PubMed     Abstract available


  17. SCHUSTER JE, Hamdan L, Dulek DE, Kitko CL, et al
    The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial.
    Clin Infect Dis. 2023 Oct 6:ciad534. doi: 10.1093.
    PubMed     Abstract available


  18. CONLY JM, Loeb M
    SARS-CoV-2 Exposures in a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccintion Era: A Randomized Trial is Possible During the Pandemic.
    Clin Infect Dis. 2023 Oct 5:ciad609. doi: 10.1093.
    PubMed    


  19. STEINBERG J, Bressler SS, Orell L, Thompson GC, et al
    Invasive pneumococcal disease and potential impact of pneumococcal conjugate vaccines among adults, including persons experiencing homelessness - Alaska, 2011-2020.
    Clin Infect Dis. 2023 Oct 3:ciad597. doi: 10.1093.
    PubMed     Abstract available


    September 2023
  20. BROUSSEAU N, Carazo S, Febriani Y, Padet L, et al
    Single-dose effectiveness of mpox vaccine in Quebec, Canada: test-negative design with and without adjustment for self-reported exposure risk.
    Clin Infect Dis. 2023 Sep 28:ciad584. doi: 10.1093.
    PubMed     Abstract available


  21. LOPEZ BERNAL J, Andrews N, Gower C, Stowe J, et al
    Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From Coronavirus Disease 2019 in Adults Aged >/=70 Years.
    Clin Infect Dis. 2023 Sep 27:ciab881. doi: 10.1093.
    PubMed     Abstract available


  22. YANG J, Lo NC, Dankwa EA, Donnelly CA, et al
    Determining herd immunity thresholds for hepatitis A virus transmission to inform vaccination strategies among people who inject drugs in 16 U.S. States.
    Clin Infect Dis. 2023 Sep 21:ciad552. doi: 10.1093.
    PubMed     Abstract available


  23. FELDMAN RG, Antonelli-Incalzi R, Steenackers K, Lee DG, et al
    Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions.
    Clin Infect Dis. 2023 Sep 12:ciad471. doi: 10.1093.
    PubMed     Abstract available


  24. LAI SW
    Comment on Parameswaran et al's "Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine".
    Clin Infect Dis. 2023;77:801-802.
    PubMed    


    August 2023
  25. WONG CKH, Lau KTK, Au ICH, Lau EHY, et al
    Comparison of bivalent and monovalent mRNA vaccine boosters.
    Clin Infect Dis. 2023 Aug 30:ciad519. doi: 10.1093.
    PubMed     Abstract available


  26. GRIGGS EP, Mitchell PK, Lazariu V, Gaglani M, et al
    Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 States, June 2021-March 2023.
    Clin Infect Dis. 2023 Aug 26:ciad505. doi: 10.1093.
    PubMed     Abstract available


  27. TATE JE, Mwenda JM, Keita AM, Tapsoba TW, et al
    Evaluation of Intussusception Following Pentavalent Rotavirus Vaccine (RotaTeq) Administration in Five Countries in Africa.
    Clin Infect Dis. 2023 Aug 19:ciad492. doi: 10.1093.
    PubMed     Abstract available


  28. MOMBELLI M, Neofytos D, Huynh-Do U, Sanchez-Cespedes J, et al
    Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
    Clin Infect Dis. 2023 Aug 16:ciad477. doi: 10.1093.
    PubMed     Abstract available


  29. FELD JJ, Bruneau J, Dore GJ, Ghany MG, et al
    Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available


  30. BILINSKI A, Slimovitch R, Mendlowitz A, Feld JJ, et al
    First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available


  31. LIANG TJ, Feld JJ, Shoukry NH, Thomas DL, et al
    Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real?
    Clin Infect Dis. 2023;77.
    PubMed    


    July 2023
  32. POZZI C, Sarti R, Levi R, Mollura M, et al
    Association between duration of SARS-CoV-2 positivity and long COVID.
    Clin Infect Dis. 2023 Jul 22:ciad434. doi: 10.1093.
    PubMed     Abstract available


  33. MOSCHESE D, Bianchi M, Cossu MV, Salari F, et al
    Neutralizing antibody titers induced by JYNNEOS vaccine in unrecognized previous mpox virus exposed individuals.
    Clin Infect Dis. 2023 Jul 7:ciad412. doi: 10.1093.
    PubMed    


  34. MATUSALI G, Mazzotta V, Piselli P, Bettini A, et al
    Asymptomatic Mpox infection in subjects presenting for MVA-BN vaccine.
    Clin Infect Dis. 2023 Jul 7:ciad414. doi: 10.1093.
    PubMed    


  35. ITANI O, Hochedez P, Benabdelmoumen G, Jidar K, et al
    Antibody titers in elderly patients after rabies post-exposure prophylaxis.
    Clin Infect Dis. 2023 Jul 5:ciad408. doi: 10.1093.
    PubMed    


  36. BAERENDS EAM, Reekie J, Andreasen SR, Staerke NB, et al
    Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study.
    Clin Infect Dis. 2023 Jul 1:ciad402. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  37. FAUST JS, Kumar A, Shah J, Khadke S, et al
    Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years.
    Clin Infect Dis. 2023 Jun 30:ciad400. doi: 10.1093.
    PubMed     Abstract available


  38. WILCK M, Cornely OA, Cordonnier C, Velez JD, et al
    A phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in allogeneic hematopoietic cell transplant recipients (PNEU-STEM).
    Clin Infect Dis. 2023 Jun 20:ciad349. doi: 10.1093.
    PubMed     Abstract available


  39. AUERSWALD H, Maestri A, Touch S, In S, et al
    Side-by-side comparative study of the immunogenicity of the intramuscular and intradermal rabies post-exposure prophylaxis regimens in a cohort of suspected RABV exposed individuals.
    Clin Infect Dis. 2023 Jun 20:ciad304. doi: 10.1093.
    PubMed     Abstract available


  40. UPASANI V, Townsend K, Wu MY, Carr EJ, et al
    Commercial immunoglobulin products contain neutralising antibodies against SARS-CoV-2 spike protein.
    Clin Infect Dis. 2023 Jun 20:ciad368. doi: 10.1093.
    PubMed     Abstract available


  41. NAFICY A, Kuxhausen A, Pirrotta P, Leav B, et al
    No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial.
    Clin Infect Dis. 2023 Jun 19:ciad361. doi: 10.1093.
    PubMed     Abstract available


  42. WIESE AD, Mitchel E, Ndi D, Markus TM, et al
    Risk of Acute Myocardial Infarction Among Patients With Laboratory-Confirmed Invasive Pneumococcal Disease: A Self-Controlled Case Series Study.
    Clin Infect Dis. 2023;76:2171-2177.
    PubMed     Abstract available


  43. LEWNARD JA, Hong V, Bruxvoort KJ, Grant LR, et al
    Burden of lower respiratory tract infections preventable by adult immunization with 15- and 20-valent pneumococcal conjugate vaccines in the United States.
    Clin Infect Dis. 2023 Jun 9:ciad355. doi: 10.1093.
    PubMed     Abstract available


    May 2023
  44. KOJIMA N, Adams K, Self WH, Gaglani M, et al
    Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
    Clin Infect Dis. 2023 May 31:ciad276. doi: 10.1093.
    PubMed     Abstract available


  45. LUNDGREN J
    Patients Hospitalized With Coronavirus Disease 2019: A Diverse Population.
    Clin Infect Dis. 2023 May 31:ciad280. doi: 10.1093.
    PubMed    



  46. Correction to: Relative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Period-Un
    Clin Infect Dis. 2023 May 30:ciad256. doi: 10.1093.
    PubMed    


  47. CHAVES SS, Naeger S, Lounaci K, Zuo Y, et al
    High-dose influenza vaccine is associated with reduced mortality among older adults with breakthrough influenza even when there is poor vaccine-strain match.
    Clin Infect Dis. 2023 May 29:ciad322. doi: 10.1093.
    PubMed     Abstract available


  48. ASTURIAS EJ, Excler JL, Ackland J, Cavaleri M, et al
    Safety of Streptococcus pyogenes vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post Marketing Monitoring.
    Clin Infect Dis. 2023 May 26:ciad311. doi: 10.1093.
    PubMed     Abstract available


  49. ZENG G, Zhou Y
    Association of virus variation and vaccination status with post-acute sequelae after SARS-cov-2 infection.
    Clin Infect Dis. 2023 May 10:ciad292. doi: 10.1093.
    PubMed    


  50. KO JY, Pham H, Anglin O, Chai SJ, et al
    Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020-August 2022.
    Clin Infect Dis. 2023 May 3:ciad266. doi: 10.1093.
    PubMed     Abstract available


  51. HASSANZADEH H, Baber J, Begier E, Noriega DC, et al
    Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STRIVE Randomized Clinical Trial.
    Clin Infect Dis. 2023 May 1:ciad218. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  52. PROCTOR RA
    Development of a Staphylococcus aureus Vaccine: An On-going Journey.
    Clin Infect Dis. 2023 Apr 29:ciad217. doi: 10.1093.
    PubMed    


  53. DE REZENDE IM, McClure MA, Pereira LS, Fradico JRB, et al
    Characterization and investigation of risk factors for Late-relapsing hepatitis after yellow fever.
    Clin Infect Dis. 2023 Apr 26:ciad249. doi: 10.1093.
    PubMed     Abstract available


  54. KASUMBA IN, Badji H, Powell H, Hossain MJ, et al
    Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  55. HOSSAIN MJ, Powell H, Sow SO, Omore R, et al
    Clinical and Epidemiologic Features of Cryptosporidium-Associated Diarrheal Disease Among Young Children Living in Sub-Saharan Africa: The Vaccine Impact on Diarrhea in Africa (VIDA) Study.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  56. BERENDES DM, Omore R, Prentice-Mott G, Fagerli K, et al
    Exploring Survey-Based Water, Sanitation, and Animal Associations With Enteric Pathogen Carriage: Comparing Results in a Cohort of Cases With Moderate-to-Severe Diarrhea to Those in Controls in the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 20
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  57. OMORE R, Powell H, Sow SO, Jahangir Hossain M, et al
    Norovirus Disease Among Children <5 Years in 3 Sub-Saharan African Countries: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  58. DEICHSEL EL, Keita AM, Verani JR, Powell H, et al
    Management of Diarrhea in Young Children in Sub-Saharan Africa: Adherence to World Health Organization Recommendations During the Global Enteric Multisite Study (2007-2011) and the Vaccine Impact of Diarrhea in Africa (VIDA) Study (2015-2018).
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  59. KEITA AM, Doh S, Sow SO, Powell H, et al
    Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  60. BERENDES DM, Fagerli K, Kim S, Nasrin D, et al
    Survey-Based Assessment of Water, Sanitation, and Animal-Associated Risk Factors for Moderate-to-Severe Diarrhea in the Vaccine Impact on Diarrhea in Africa (VIDA) Study: The Gambia, Mali, and Kenya, 2015-2018.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  61. NASRIN D, Liang Y, Verani JR, Powell H, et al
    Stunting Following Moderate-to-Severe Diarrhea Among Children Aged <5 Years in Africa Before and After Rotavirus Vaccine Introduction: A Comparison of the Global Enteric Multicenter Study and the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  62. BUCHWALD AG, Verani JR, Keita AM, Jahangir Hossain M, et al
    Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  63. SCHWARTZ LM, Oshinsky J, Reymann M, Esona MD, et al
    Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  64. STEELE AD, Armah GE, Mwenda JM, Kirkwood CD, et al
    The Full Impact of Rotavirus Vaccines in Africa Has Yet to Be Realized.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  65. OCHIENG JB, Powell H, Sugerman CE, Omore R, et al
    Epidemiology of Enteroaggregative, Enteropathogenic, and Shiga Toxin-Producing Escherichia coli Among Children Aged <5 Years in 3 Countries in Africa, 2015-2018: Vaccine Impact on Diarrhea in Africa (VIDA) Study.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  66. MARCENAC P, Traore A, Kim S, Prentice-Mott G, et al
    Giardia Detection and Codetection With Other Enteric Pathogens in Young Children in the Vaccine Impact on Diarrhea in Africa (VIDA) Case-Control Study: 2015-2018.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  67. DEICHSEL EL, Powell H, Troeger C, Hossain MJ, et al
    Drivers of Decline in Diarrhea Mortality Between GEMS and VIDA Studies.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  68. NASRIN D, Liang Y, Powell H, Casanova IG, et al
    Moderate-to-Severe Diarrhea and Stunting Among Children Younger Than 5 Years: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  69. KASUMBA IN, Powell H, Omore R, Hossain MJ, et al
    Prevalence of Salmonella in Stool During the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  70. POWELL H, Liang Y, Neuzil KM, Jamka LP, et al
    A Description of the Statistical Methods for the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  71. AWUOR AO, Ogwel B, Powell H, Verani JR, et al
    Antibiotic-Prescribing Practices for Management of Childhood Diarrhea in 3 Sub-Saharan African Countries: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available


  72. JOFFE AR, Elliott A, Eapen R, Milburn C, et al
    Is vaccination acting as a placebo in preventing symptoms of Long-COVID?
    Clin Infect Dis. 2023 Apr 19:ciad234. doi: 10.1093.
    PubMed    


  73. CHEN GJ, Sun HY, Lin KY, Hsieh SM, et al
    A randomized clinical trial of one-dose versus accelerated two-dose schedule for hepatitis A virus revaccination among people with HIV who were non-responders or had seroreversion after primary HAV vaccination.
    Clin Infect Dis. 2023 Apr 10:ciad206. doi: 10.1093.
    PubMed     Abstract available


  74. MARKS KM, Kang M, Umbleja T, Avihingsanon A, et al
    Immunogenicity and Safety of Hepatitis B vaccine with a Toll-like Receptor 9 Agonist Adjuvant (HEPLISAV-B) in HBV Vaccine-naive People with HIV.
    Clin Infect Dis. 2023 Apr 5:ciad201. doi: 10.1093.
    PubMed     Abstract available


    March 2023
  75. MACFADDEN DR, Maxwell C, Bowdish D, Bronskill S, et al
    COVID-19 Vaccination is Associated with Reduced Outpatient Antibiotic Prescribing In Older Adults with Confirmed SARS-CoV-2: A Population Wide Cohort Study.
    Clin Infect Dis. 2023 Mar 31:ciad190. doi: 10.1093.
    PubMed     Abstract available


  76. HOLZBAUER SM, Schrodt CA, Prabhu RM, Asch-Kendrick RJ, et al
    Fatal Human Rabies Infection with Suspected Host-mediated Failure of Post-Exposure Prophylaxis Following a Recognized Zoonotic Exposure-Minnesota, 2021.
    Clin Infect Dis. 2023 Mar 29:ciad098. doi: 10.1093.
    PubMed     Abstract available


  77. FERREIRA VH, Ierullo M, Mavandadnejad F, Kurtesi A, et al
    Omicron BA.4/5 neutralization and T-cell responses in organ transplant recipients after Booster mRNA vaccine: a Multicenter Cohort Study.
    Clin Infect Dis. 2023 Mar 28:ciad175. doi: 10.1093.
    PubMed     Abstract available


  78. ATKINS KE, Hodgson D
    Vaccination of older adults against RSV: the final pieces of the puzzle.
    Clin Infect Dis. 2023 Mar 23:ciad162. doi: 10.1093.
    PubMed    


  79. VAN EFFELTERRE T, Hens N, White LJ, Gravenstein S, et al
    Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with a Dynamic Transmission Model.
    Clin Infect Dis. 2023 Mar 23:ciad161. doi: 10.1093.
    PubMed     Abstract available


  80. HOFFMAN SA, LeBoa C, Date K, Haldar P, et al
    Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.
    Clin Infect Dis. 2023 Mar 22:ciad132. doi: 10.1093.
    PubMed     Abstract available


  81. CAREY ME
    Gateway to typhoid conjugate vaccine introduction in India and beyond - programmatic effectiveness of a public sector typhoid conjugate vaccine campaign in Navi Mumbai.
    Clin Infect Dis. 2023 Mar 22:ciad134. doi: 10.1093.
    PubMed    


  82. CHUNG H, Campitelli MA, Buchan SA, Campigotto A, et al
    Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults.
    Clin Infect Dis. 2023 Mar 21:ciad148. doi: 10.1093.
    PubMed     Abstract available



  83. Correction to: Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
    Clin Infect Dis. 2023 Mar 15:ciac607. doi: 10.1093.
    PubMed    


  84. OGALE YP, Baird N, Townsend MB, Berry I, et al
    Evidence of mpox virus infection among persons without characteristic lesions or rash presenting for first dose of JYNNEOS vaccine-District of Columbia, August 2022.
    Clin Infect Dis. 2023 Mar 14:ciad145. doi: 10.1093.
    PubMed     Abstract available



  85. Correction to: Duration of Protection After Vaccination Against Yellow Fever - Systematic Review and Meta-analysis.
    Clin Infect Dis. 2023 Mar 11:ciac822. doi: 10.1093.
    PubMed    


  86. KAHLERT CR, Strahm C, Gusewell S, Cusini A, et al
    Post-acute sequelae after SARS-CoV-2 infection by viral variant and vaccination status: a multicenter cross-sectional study.
    Clin Infect Dis. 2023 Mar 11:ciad143. doi: 10.1093.
    PubMed     Abstract available


  87. NIRENBERG E, Perencevich EN
    Understanding and Improving Vaccine Effectiveness Estimates in the Age of Widespread Background Immunity: A Step Towards Improved Science Communication.
    Clin Infect Dis. 2023 Mar 8:ciad124. doi: 10.1093.
    PubMed     Abstract available


  88. STABLER S, Lamblin C, Gaillard S, Just N, et al
    High Frequency of Specific Polysaccharide Antibody Deficiency in Adults With Unexplained, Recurrent and/or Severe Infections With Encapsulated Bacteria.
    Clin Infect Dis. 2023;76:800-808.
    PubMed     Abstract available


  89. LEA AN, Leyden WA, Sofrygin O, Marafino BJ, et al
    Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
    Clin Infect Dis. 2023 Mar 2:ciad084. doi: 10.1093.
    PubMed     Abstract available


  90. IMP BM, Levine T, Satre DD, Skarbinski J, et al
    Influenza Vaccination Uptake and Associated Factors Among Adults With and Without HIV in a Large, Integrated Health Care System.
    Clin Infect Dis. 2023 Mar 1:ciad106. doi: 10.1093.
    PubMed     Abstract available



  91. Correction to: Effectiveness of Messenger RNA-based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.
    Clin Infect Dis. 2023 Mar 1:ciac810. doi: 10.1093.
    PubMed    


    February 2023

  92. Correction to: Coronavirus Disease 2019 [COVID-19] Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study.
    Clin Infect Dis. 2023 Feb 8:ciac632. doi: 10.1093.
    PubMed    


  93. KOMPANIYETS L, Wiegand RE, Oyalowo AC, Bull-Otterson L, et al
    Relative effectiveness of COVID-19 vaccination and booster dose combinations among 18.9 million vaccinated adults during the early SARS-CoV-2 Omicron period - United States, January 1, 2022-March 31, 2022.
    Clin Infect Dis. 2023 Feb 8:ciad063. doi: 10.1093.
    PubMed     Abstract available


  94. HOY G, Kuan G, Lopez R, Sanchez N, et al
    The Spectrum of Influenza in Children.
    Clin Infect Dis. 2023;76:e1012-e1020.
    PubMed     Abstract available


  95. AMIRTHALINGAM G, Campbell H, Ribeiro S, Stowe J, et al
    Optimization of Timing of Maternal Pertussis Immunization From 6 Years of Postimplementation Surveillance Data in England.
    Clin Infect Dis. 2023;76:e1129-e1139.
    PubMed     Abstract available


  96. SCHULTE J, Short K, Persse D
    Management and Control Issues Related to Two Mumps Outbreaks in Houston: Future Implications.
    Clin Infect Dis. 2023;76:e1416-e1420.
    PubMed     Abstract available


  97. MAIER HE, Kuan G, Gresh L, Chowell G, et al
    The Nicaraguan Pediatric Influenza Cohort Study, 2011-2019: Influenza Incidence, Seasonality, and Transmission.
    Clin Infect Dis. 2023;76:e1094-e1103.
    PubMed     Abstract available


    January 2023
  98. MELICA G, Bartolucci P, Audureau E, Le Corvoisier P, et al
    Immunological efficacy of pneumococcal vaccination including the 13-valent pneumococcal vaccine in adult patients with sickle-cell disease: results of the randomized DREVAC controlled trial.
    Clin Infect Dis. 2023 Jan 27:ciad037. doi: 10.1093.
    PubMed     Abstract available



  99. Correction to: Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
    Clin Infect Dis. 2023 Jan 18:ciac584. doi: 10.1093.
    PubMed    


  100. BONAZZETTI C, Tazza B, Gibertoni D, Pasquini Z, et al
    Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort.
    Clin Infect Dis. 2023 Jan 13:ciad016. doi: 10.1093.
    PubMed     Abstract available



  101. Correction to: Prevention of Neisseria gonorrhoeae With Meningococcal B Vaccine: A Matched Cohort Study in Southern California.
    Clin Infect Dis. 2023 Jan 11:ciac936. doi: 10.1093.
    PubMed    



  102. Correction to: Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2023 Jan 6:ciac964. doi: 10.1093.
    PubMed    


  103. DALTON AF, Weber ZA, Allen KS, Stenehjem E, et al
    Relationships between social vulnerability and COVID-19 vaccination coverage and vaccine effectiveness.
    Clin Infect Dis. 2023 Jan 6:ciad003. doi: 10.1093.
    PubMed     Abstract available


  104. TITANJI BK
    The Last Mile Problem - COVID-19 Vaccine Coverage Among the Most Socially Vulnerable.
    Clin Infect Dis. 2023 Jan 6:ciad006. doi: 10.1093.
    PubMed    


  105. WINOKUR PL, Hegmann TE, Keitel WA, Bernstein DI, et al
    Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults.
    Clin Infect Dis. 2023 Jan 5:ciac983. doi: 10.1093.
    PubMed     Abstract available


  106. NEUZIL KM, Anderson EJ, Frenck RW, Frey SE, et al
    Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses.
    Clin Infect Dis. 2023 Jan 5:ciac982. doi: 10.1093.
    PubMed     Abstract available



  107. Correction to: Anogenital Human Papillomavirus (HPV) Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial.
    Clin Infect Dis. 2023 Jan 4:ciac768. doi: 10.1093.
    PubMed    


    December 2022
  108. HERRING MK, Romine JK, Wesley MG, Ellingson KD, et al
    SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses.
    Clin Infect Dis. 2022 Dec 29:ciac976. doi: 10.1093.
    PubMed     Abstract available


  109. THET AK, Kelly PJ, Kasule SN, Shah AK, et al
    The use of vaccinia immune globulin in the treatment of severe mpox virus infection in HIV/AIDS.
    Clin Infect Dis. 2022 Dec 26:ciac971. doi: 10.1093.
    PubMed     Abstract available


  110. ROBINSON ML, Morris CP, Betz JF, Zhang Y, et al
    Impact of SARS-CoV-2 variants on inpatient clinical outcome.
    Clin Infect Dis. 2022 Dec 19:ciac957. doi: 10.1093.
    PubMed     Abstract available


  111. NEHME M, Vetter P, Chappuis F, Kaiser L, et al
    Prevalence of post-COVID Condition 12 Weeks after Omicron Infection Compared to Negative Controls and Association with Vaccination Status.
    Clin Infect Dis. 2022 Dec 15:ciac947. doi: 10.1093.
    PubMed     Abstract available


  112. PRICE AM, Flannery B, Talbot HK, Grijalva CG, et al
    Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
    Clin Infect Dis. 2022 Dec 12:ciac941. doi: 10.1093.
    PubMed     Abstract available


  113. PRUNAS O, Weinberger DM, Pitzer VE, Gazit S, et al
    Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel.
    Clin Infect Dis. 2022 Dec 9:ciac315. doi: 10.1093.
    PubMed     Abstract available


  114. EDWARDS KM, Neuzil KM
    Developing mucosal vaccines for SARS-CoV-2: What will it take?
    Clin Infect Dis. 2022 Dec 9:ciac935. doi: 10.1093.
    PubMed    


  115. COHEN JI, Dropulic L, Wang K, Gangler K, et al
    Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination.
    Clin Infect Dis. 2022 Dec 9:ciac934. doi: 10.1093.
    PubMed     Abstract available


    November 2022
  116. TADESSE BT, Bravo L, Marks F, Aziz AB, et al
    Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines.
    Clin Infect Dis. 2022 Nov 26:ciac914. doi: 10.1093.
    PubMed     Abstract available


  117. LEVIN MJ, Ustianowski A, Thomas S, Templeton A, et al
    AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of Symptomatic COVID-19.
    Clin Infect Dis. 2022 Nov 22:ciac899. doi: 10.1093.
    PubMed     Abstract available


  118. MARTIN C, Dauby N
    Guiding yellow fever vaccination strategy worldwide: booster = better?
    Clin Infect Dis. 2022 Nov 16. pii: 6830230. doi: 10.1093.
    PubMed    


  119. SHAH MM, Spencer BR, Feldstein LR, Haynes JM, et al
    Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021.
    Clin Infect Dis. 2022 Nov 14. pii: 6825618. doi: 10.1093.
    PubMed     Abstract available


  120. BARDA N, Canetti M, Gilboa M, Asraf K, et al
    The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 Nov 11. pii: 6821340. doi: 10.1093.
    PubMed     Abstract available


  121. BLOSSEY AM, Bruckner S, May M, Parzmair GP, et al
    VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including COVID-19 in the Elderly: a phase III randomised, double-blind, placebo-controlled, multicenter clinical study.
    Clin Infect Dis. 2022 Nov 11. pii: 6821343. doi: 10.1093.
    PubMed     Abstract available


  122. OTERO S, Miller ES, Sunderraj A, Shanes ED, et al
    Maternal Antibody Response and Transplacental Transfer Following SARS-CoV-2 Infection or Vaccination in Pregnancy.
    Clin Infect Dis. 2022 Nov 9. pii: 6812657. doi: 10.1093.
    PubMed     Abstract available


  123. SIEGHART D, Hana CA, Haslacher H, Perkmann T, et al
    MULTI-PARAMETRIC PREDICTION MODELS FOR COVID-19 VACCINE SELECTION: RESULTS OF A COMPARATIVE POPULATION-BASED COHORT STUDY.
    Clin Infect Dis. 2022 Nov 4. pii: 6795267. doi: 10.1093.
    PubMed     Abstract available


  124. TENFORDE MW, Patel MM, Lewis NM, Adams K, et al
    Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness, United States, 2022.
    Clin Infect Dis. 2022 Nov 3. pii: 6795261. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  125. BETTINGER JA, Irvine MA, Shulha HP, Valiquette L, et al
    Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network.
    Clin Infect Dis. 2022 Oct 31. pii: 6780916. doi: 10.1093.
    PubMed     Abstract available


  126. ASARE K, Andine T, Naicker N, Dorward J, et al
    Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial.
    Clin Infect Dis. 2022 Oct 15. pii: 6761890. doi: 10.1093.
    PubMed     Abstract available


  127. MALOSH RE, McGovern I, Monto AS
    Influenza During the 2010-2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions.
    Clin Infect Dis. 2022 Oct 11. pii: 6758391. doi: 10.1093.
    PubMed     Abstract available


  128. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
    Clin Infect Dis. 2022 Oct 10. pii: 6754597. doi: 10.1093.
    PubMed     Abstract available


  129. BISWAL S, Patel SS, Rauscher M
    Safety of Dengue Vaccine?
    Clin Infect Dis. 2022 Oct 5. pii: 6748245. doi: 10.1093.
    PubMed    


  130. FIDLER S, Fox J, Tipoe T, Longet S, et al
    Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
    Clin Infect Dis. 2022 Oct 5. pii: 6748267. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  131. ISLAM MT, Date K, Khan AI, Bhuiyan TR, et al
    Co-administration of Oral Cholera Vaccine with Oral Polio Vaccine among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference.
    Clin Infect Dis. 2022 Sep 22. pii: 6711550. doi: 10.1093.
    PubMed     Abstract available


  132. FLOREA A, Sy LS, Qian L, Ackerson BK, et al
    Effectiveness of mRNA-1273 vaccine booster against COVID-19 in immunocompetent adults.
    Clin Infect Dis. 2022 Sep 22. pii: 6711079. doi: 10.1093.
    PubMed     Abstract available


  133. SIANGPHOE U, Baden LR, El Sahly HM, Essink B, et al
    Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials.
    Clin Infect Dis. 2022 Sep 20. pii: 6708263. doi: 10.1093.
    PubMed     Abstract available


  134. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Molnupiravir in High Risk Patients: a Propensity Score Matched Analysis.
    Clin Infect Dis. 2022 Sep 20. pii: 6708264. doi: 10.1093.
    PubMed     Abstract available


  135. ONO S, Michihata N, Yamana H, Uemura K, et al
    Comparative effectiveness of BNT162b2 and mRNA-1273 booster dose after BNT162b2 primary vaccination against the Omicron variants: A retrospective cohort study using large-scale population-based registries in Japan.
    Clin Infect Dis. 2022 Sep 18. pii: 6696997. doi: 10.1093.
    PubMed     Abstract available


  136. BOULWARE DR, Murray TA, Proper JL, Tignanelli CJ, et al
    Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial.
    Clin Infect Dis. 2022 Sep 17. pii: 6702474. doi: 10.1093.
    PubMed     Abstract available


  137. HSU CK, Lai CC
    The confounding effect of vaccine status.
    Clin Infect Dis. 2022 Sep 16. pii: 6701809. doi: 10.1093.
    PubMed    


  138. TURNER P, Sa-Leao R, Greenhill A, Leach A, et al
    World Health Organization (WHO) Standard Methods for Pneumococcal Carriage Studies.
    Clin Infect Dis. 2022;75:924-925.
    PubMed    


  139. MAGNUS MC, Haberg SE, Carlsen EO, Kwong JC, et al
    Pregnancy status at the time of COVID-19 vaccination and incidence of SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Sep 8. pii: 6693880. doi: 10.1093.
    PubMed     Abstract available


  140. NIKAS A, Ahmed H, Zarnitsyna VI
    Estimating Waning of Vaccine Effectiveness: a Simulation Study.
    Clin Infect Dis. 2022 Sep 3. pii: 6691361. doi: 10.1093.
    PubMed     Abstract available


  141. VAN DIJCK C, Hens N, Kenyon C, Tsoumanis A, et al
    The roles of unrecognized monkeypox cases, contact isolation and vaccination in determining epidemic size in Belgium. A modelling study.
    Clin Infect Dis. 2022 Sep 2. pii: 6686539. doi: 10.1093.
    PubMed     Abstract available


  142. DE SILVA A
    Safety of Dengue Vaccine?
    Clin Infect Dis. 2022 Sep 1. pii: 6681127. doi: 10.1093.
    PubMed    


    August 2022
  143. MATHIS AD, Clemmons NS, Redd SB, Pham H, et al
    Maintenance of Measles Elimination Status in the United States for 20 Years Despite Increasing Challenges.
    Clin Infect Dis. 2022;75:416-424.
    PubMed     Abstract available


  144. ORIJE MRP, Garcia-Fogeda I, Van Dyck W, Corbiere V, et al
    Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune Responses.
    Clin Infect Dis. 2022;75:442-452.
    PubMed     Abstract available


  145. WIRTH KE, Edwards JK, Feinstein L, Breskin A, et al
    When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose.
    Clin Infect Dis. 2022 Aug 30. pii: 6679241. doi: 10.1093.
    PubMed    


  146. GAGLANI M, Kim SS, Naleway AL, Levine MZ, et al
    Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
    Clin Infect Dis. 2022 Aug 29. pii: 6678123. doi: 10.1093.
    PubMed     Abstract available


  147. AMIN AB, Tate JE, Waller LA, Lash TL, et al
    Monovalent rotavirus vaccine efficacy against different rotavirus genotypes: a pooled analysis of Phase II and III trial data.
    Clin Infect Dis. 2022 Aug 29. pii: 6678127. doi: 10.1093.
    PubMed     Abstract available


  148. BANERJEE E, Paul P, Griffith J, Laine E, et al
    Impact of Isolation and Exclusion as a Public Health Strategy to Contain Measles Virus Transmission During a Measles Outbreak.
    Clin Infect Dis. 2022;75:152-154.
    PubMed     Abstract available


  149. ANDREJKO K, Ratnasiri B, Lewnard JA
    Association of Pneumococcal Serotype With Susceptibility to Antimicrobial Drugs: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2022;75:131-140.
    PubMed     Abstract available


  150. GANATRA S, Dani SS, Ahmad J, Kumar A, et al
    Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19.
    Clin Infect Dis. 2022 Aug 20. pii: 6672670. doi: 10.1093.
    PubMed     Abstract available


  151. NASREEN S, Febriani Y, Velasquez Garcia HA, Zhang G, et al
    Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study.
    Clin Infect Dis. 2022 Aug 17. pii: 6668859. doi: 10.1093.
    PubMed     Abstract available


  152. KARABA AH, Zhou W, Li S, Aytenfisu TY, et al
    Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2022 Aug 12. pii: 6663288. doi: 10.1093.
    PubMed     Abstract available


  153. PECK H, Anbumurali N, McMahon K, Freeman K, et al
    Detection of influenza in managed quarantine in Australia and the estimated risk of importation.
    Clin Infect Dis. 2022 Aug 12. pii: 6663754. doi: 10.1093.
    PubMed     Abstract available


  154. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
    Clin Infect Dis. 2022 Aug 4. pii: 6655523. doi: 10.1093.
    PubMed     Abstract available


  155. PRAY IW, Grajewski B, Morris C, Modji K, et al
    Measuring work-related risk of COVID-19: comparison of COVID-19 incidence by occupation and industry - Wisconsin, September 2020-May 2021.
    Clin Infect Dis. 2022 Aug 4. pii: 6655522. doi: 10.1093.
    PubMed     Abstract available


  156. ARASHIRO T, Arima Y, Muraoka H, Sato A, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study).
    Clin Infect Dis. 2022 Aug 3. pii: 6653543. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  157. LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
    Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
    PubMed     Abstract available


  158. ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
    Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
    Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
    PubMed     Abstract available


  159. SAHNI LC, Naioti EA, Olson SM, Campbell AP, et al
    Sustained within-season vaccine effectiveness against influenza-associated hospitalization in children: Evidence from the New Vaccine Surveillance Network, 2015-2016 through 2019-2020.
    Clin Infect Dis. 2022 Jul 22. pii: 6648556. doi: 10.1093.
    PubMed     Abstract available


  160. KLING K, Domingo C, Bogdan C, Duffy S, et al
    Duration of protection after vaccination against yellow fever - systematic review and meta-analysis.
    Clin Infect Dis. 2022 Jul 20. pii: 6646957. doi: 10.1093.
    PubMed     Abstract available


  161. HATFIELD KM, Baggs J, Wolford H, Fang M, et al
    Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
    Clin Infect Dis. 2022 Jul 20. pii: 6646955. doi: 10.1093.
    PubMed     Abstract available


  162. PARAMESWARAN GI, Wattengel BA, Chua HC, Swiderek J, et al
    Increased Stroke Risk Following Herpes Zoster Infection and Protection with Zoster Vaccine.
    Clin Infect Dis. 2022 Jul 7. pii: 6633277. doi: 10.1093.
    PubMed     Abstract available


  163. SANDERS JSF, Lianne Messchendorp A, de Vries RD, Baan CC, et al
    Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633280. doi: 10.1093.
    PubMed     Abstract available


  164. TURNER AN, Carter AM, Tzeng YL, Stephens DS, et al
    Infection With the US Neisseria meningitidis Urethritis Clade Does Not Lower Future Risk of Urethral Gonorrhea.
    Clin Infect Dis. 2022;74:2159-2165.
    PubMed     Abstract available


  165. MURISON KR, Grima AA, Simmons AE, Tuite AR, et al
    Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis.
    Clin Infect Dis. 2022 Jul 6. pii: 6632524. doi: 10.1093.
    PubMed     Abstract available


  166. GRANT LR, Slack MPE, Theilacker C, Vojicic J, et al
    Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children from High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
    Clin Infect Dis. 2022 Jul 5. pii: 6629370. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  167. GOOD MK, Czarnik M, Harmon KG, Aukerman D, et al
    SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021.
    Clin Infect Dis. 2022 Jun 30. pii: 6623463. doi: 10.1093.
    PubMed     Abstract available


  168. GLATMAN-FREEDMAN A, Feldman SF, Hershkovitz Y, Kaufman Z, et al
    Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis.
    Clin Infect Dis. 2022 Jun 28. pii: 6619125. doi: 10.1093.
    PubMed     Abstract available


  169. MOLINE HL, Keaton A, Rice W, Varghese J, et al
    Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
    Clin Infect Dis. 2022 Jun 27. pii: 6618595. doi: 10.1093.
    PubMed     Abstract available


  170. OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
    Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
    Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
    PubMed     Abstract available


  171. IDOKO OT, Usuf E, Okomo U, Wonodi C, et al
    SARS-CoV-2 in Africa: current considerations and future projections.
    Clin Infect Dis. 2022 Jun 25. pii: 6617636. doi: 10.1093.
    PubMed     Abstract available


  172. KUTTY PK, Stuckey MJ, Koumans EH
    Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations.
    Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
    PubMed     Abstract available


  173. CHOI D, Nielsen J, Waller LA, Patel SA, et al
    The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination.
    Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
    PubMed     Abstract available


  174. PLOTKIN SA
    Why We Need Precision Vaccinology.
    Clin Infect Dis. 2022 Jun 23. pii: 6615391. doi: 10.1093.
    PubMed    


  175. MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
    Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
    Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
    PubMed     Abstract available


  176. OHLSEN EC, Yankey D, Pezzi C, Kriss JL, et al
    COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022.
    Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
    PubMed     Abstract available


  177. BROSH-NISSIMOV T, Hussein K, Wiener-Well Y, Orenbuch-Harroch E, et al
    Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose.
    Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
    PubMed     Abstract available


  178. ROSKOSKY M, Moni G, Kawakami V, Lambert J, et al
    SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
    PubMed     Abstract available


  179. VU DM, Vu DTB, Do TTT, Olmsted AE, et al
    Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
    Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
    PubMed     Abstract available


  180. SABLEROLLES RSG, Rietdijk WJR, Goorhuis A, Postma DF, et al
    Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
    Clin Infect Dis. 2022 Jun 20. pii: 6611568. doi: 10.1093.
    PubMed     Abstract available


  181. KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
    Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611479. doi: 10.1093.
    PubMed     Abstract available


  182. RICHARDSON VL, Franco MAC, Marquez AB, Valdez LM, et al
    Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
    PubMed     Abstract available


  183. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination.
    Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
    PubMed     Abstract available


  184. CARRIM M, Tempia S, Thindwa D, Martinson NA, et al
    Unmasking pneumococcal carriage in a high HIV prevalence population in two community cohorts with a high prevalence of HIV in South Africa, 2016-2018: the PHIRST study.
    Clin Infect Dis. 2022 Jun 19. pii: 6611495. doi: 10.1093.
    PubMed     Abstract available


  185. MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
    Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.
    Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
    PubMed     Abstract available


  186. LIM SY, Park S, Kim JY, Kim S, et al
    Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.
    Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
    PubMed     Abstract available


  187. RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
    Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
    PubMed     Abstract available


  188. BUSCH MP, Stramer SL, Stone M, Yu EA, et al
    Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
    PubMed     Abstract available


  189. LI ZN, Liu F, Jefferson S, Horner L, et al
    Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
    Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
    PubMed     Abstract available


  190. TOP KA, Chen RT, Levy O, Ozonoff A, et al
    Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services.
    Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
    PubMed     Abstract available


  191. WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
    mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
    PubMed     Abstract available


  192. BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
    SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021.
    Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
    PubMed     Abstract available


  193. LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
    Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
    PubMed     Abstract available


  194. LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
    Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine.
    Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
    PubMed     Abstract available


  195. NACHEGA JB, Sam-Agudu NA, Siedner MJ, Rosenthal PJ, et al
    Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries.
    Clin Infect Dis. 2022 Jun 8. pii: 6603568. doi: 10.1093.
    PubMed     Abstract available


  196. NACHEGA JB, Sam-Agudu NA, Machekano RN, Rosenthal PJ, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis.
    Clin Infect Dis. 2022 Jun 8. pii: 6603567. doi: 10.1093.
    PubMed     Abstract available


  197. RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
    Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among Health Care Workers with a Vaccine Mandate.
    Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
    PubMed     Abstract available


  198. STRAUS W, Urdaneta V, Esposito DB, Mansi JA, et al
    Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide.
    Clin Infect Dis. 2022 Jun 6. pii: 6603291. doi: 10.1093.
    PubMed     Abstract available


  199. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients.
    Clin Infect Dis. 2022 Jun 2. pii: 6599020. doi: 10.1093.
    PubMed     Abstract available


  200. BRUXVOORT KJ, Lewnard JA, Chen LH, Tseng HF, et al
    Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California.
    Clin Infect Dis. 2022 Jun 1. pii: 6596517. doi: 10.1093.
    PubMed     Abstract available


  201. HAVERS FP, Skoff TH, Rench MA, Epperson M, et al
    Maternal Tdap Vaccination during Pregnancy: Impact on Infant Anti-pertussis Antibody Concentrations by Maternal Pertussis Priming Series.
    Clin Infect Dis. 2022 Jun 1. pii: 6596516. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  202. ISHOLA D
    Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children.
    Clin Infect Dis. 2022 May 30. pii: 6595436. doi: 10.1093.
    PubMed     Abstract available


  203. ANGLEMYER A, McNeill A, DuBray K, Sonder GJB, et al
    Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand.
    Clin Infect Dis. 2022;74:1859-1861.
    PubMed     Abstract available


  204. MEIRING S, Tempia S, Dominic EM, de Gouveia L, et al
    Excess Invasive Meningococcal Disease Associated With Seasonal Influenza, South Africa, 2003-2018.
    Clin Infect Dis. 2022;74:1729-1735.
    PubMed     Abstract available


  205. MARRA AR, Miraglia JL, Malheiros DT, Guozhang Y, et al
    Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021.
    Clin Infect Dis. 2022 May 27. pii: 6594056. doi: 10.1093.
    PubMed     Abstract available


  206. PATEL SS, Rauscher M, Kudela M, Pang H, et al
    Clinical Safety Experience of TAK-003 for Dengue Fever: a new Tetravalent Live Attenuated Vaccine Candidate.
    Clin Infect Dis. 2022 May 26. pii: 6593313. doi: 10.1093.
    PubMed     Abstract available


  207. ZHAO M, Slotkin R, Sheth AH, Pischel L, et al
    Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
    Clin Infect Dis. 2022 May 26. pii: 6593314. doi: 10.1093.
    PubMed     Abstract available


  208. PETROS BA, Turcinovic J, Welch NL, White LF, et al
    Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations.
    Clin Infect Dis. 2022 May 25. pii: 6591846. doi: 10.1093.
    PubMed     Abstract available


  209. GRIMA AA, Murison KR, Simmons AE, Tuite AR, et al
    Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2.
    Clin Infect Dis. 2022 May 25. pii: 6591845. doi: 10.1093.
    PubMed     Abstract available


  210. EPSI NJ, Richard SA, Lindholm DA, Mende K, et al
    Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
    Clin Infect Dis. 2022 May 24. pii: 6591282. doi: 10.1093.
    PubMed     Abstract available


  211. CORRADINI P, Agrati C, Apolone G, Mantovani A, et al
    Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.
    Clin Infect Dis. 2022 May 24. pii: 6590993. doi: 10.1093.
    PubMed     Abstract available


  212. LOFGREN E, Naumova EN, Gorski J, Naumov Y, et al
    How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges.
    Clin Infect Dis. 2022 May 24. pii: 6590989. doi: 10.1093.
    PubMed     Abstract available


  213. EYAL N, Gheaus A, Gosseries A, Magalhaes M, et al
    COVID vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries' age priorities.
    Clin Infect Dis. 2022 May 24. pii: 6590988. doi: 10.1093.
    PubMed     Abstract available


  214. LAGOUSI T, Papadatou I, Strempas P, Chatzikalil E, et al
    PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION.
    Clin Infect Dis. 2022 May 24. pii: 6590985. doi: 10.1093.
    PubMed     Abstract available


  215. SHAPIRO JR, Sitaras I, Park HS, Aytenfisu TY, et al
    Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults.
    Clin Infect Dis. 2022 May 24. pii: 6590987. doi: 10.1093.
    PubMed     Abstract available


  216. ROTTENSTREICH A, Vorontsov O, Alfi O, Zarbiv G, et al
    Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination.
    Clin Infect Dis. 2022 May 24. pii: 6590984. doi: 10.1093.
    PubMed     Abstract available


  217. LEVIN-RECTOR A, Firestein L, McGibbon E, Sell J, et al
    Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021.
    Clin Infect Dis. 2022 May 20. pii: 6589783. doi: 10.1093.
    PubMed     Abstract available


  218. TENFORDE MW, Self WH, Zhu Y, Naioti EA, et al
    Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
    Clin Infect Dis. 2022 May 17. pii: 6587132. doi: 10.1093.
    PubMed     Abstract available


  219. MARTINUZZI E, Benzaquen J, Guerin O, Leroy S, et al
    A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects.
    Clin Infect Dis. 2022 May 17. pii: 6586846. doi: 10.1093.
    PubMed     Abstract available


  220. WEITZMAN ER, Kossowsky J, Blakemore LM, Cox R, et al
    Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
    Clin Infect Dis. 2022 May 17. pii: 6586840. doi: 10.1093.
    PubMed     Abstract available


  221. WEITZMAN ER, Sherman AC, Levy O
    Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
    Clin Infect Dis. 2022 May 17. pii: 6586838. doi: 10.1093.
    PubMed     Abstract available


  222. BARI A, Heymann M, Cohen RJ, Zhao R, et al
    Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  223. POH XY, Tan CW, Lee IR, Chavatte JM, et al
    Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial.
    Clin Infect Dis. 2022 May 11. pii: 6583615. doi: 10.1093.
    PubMed     Abstract available


  224. CONTI MG, Terreri S, Terrin G, Natale F, et al
    SARS-CoV-2 infection versus vaccination in pregnancy: Implications for maternal and infant immunity.
    Clin Infect Dis. 2022 May 10. pii: 6583148. doi: 10.1093.
    PubMed     Abstract available


  225. SPARKE M, Levy O
    Competing responses to global inequalities in access to COVID vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
    Clin Infect Dis. 2022 May 10. pii: 6583150. doi: 10.1093.
    PubMed     Abstract available


  226. ZURCHER K, Abela IA, Stange M, Dupont C, et al
    Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies.
    Clin Infect Dis. 2022 May 6. pii: 6582009. doi: 10.1093/cid/ciab1005.
    PubMed     Abstract available


  227. DOWLING DJ, Levy O
    A Precision Adjuvant Approach to Enhance SARS-CoV-2 Vaccines Optimized for Immunologically Distinct Vulnerable Populations.
    Clin Infect Dis. 2022 May 4. pii: 6580093. doi: 10.1093.
    PubMed     Abstract available


  228. BUTT AA, Talisa VB, Shaikh OS, Omer SB, et al
    Relative Vaccine Effectiveness of a SARS-CoV-2 mRNA Vaccine Booster Dose Against the Omicron Variant.
    Clin Infect Dis. 2022 May 3. pii: 6577096. doi: 10.1093.
    PubMed     Abstract available


  229. BEN-SHIMOL S, Regev-Yochay G, Givon-Lavi N, van der Beek BA, et al
    Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance.
    Clin Infect Dis. 2022;74:1639-1649.
    PubMed     Abstract available


    April 2022
  230. CHOW EPF, Fairley CK, Zou H, Wigan R, et al
    Correction to: Human Papillomavirus Antibody Levels Following Vaccination or Natural Infection Among Young Men Who Have Sex With Men.
    Clin Infect Dis. 2022 Apr 27. pii: 6574995. doi: 10.1093.
    PubMed    


  231. BUSKERMOLEN M, Molthof I, Voeten HA, van Twillert J, et al
    Vaccination did not prevent severe COVID in an outbreak among older residents of a nursing home, B.1.617.2 variant, July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574733. doi: 10.1093.
    PubMed    


  232. SHRESTHA NK, Shrestha P, Burke PC, Nowacki AS, et al
    Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals.
    Clin Infect Dis. 2022 Apr 27. pii: 6574819. doi: 10.1093.
    PubMed     Abstract available


  233. SHARMA A, Oda G, Holodniy M
    Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Apr 27. pii: 6574744. doi: 10.1093.
    PubMed     Abstract available


  234. SOLERA JT, Arbol BG, Alshahrani A, Bahinskaya I, et al
    Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Clin Infect Dis. 2022 Apr 21. pii: 6571785. doi: 10.1093.
    PubMed     Abstract available


  235. ZAHRA FT, Grubbs G, Dummer K, Tremoulet AH, et al
    Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.
    Clin Infect Dis. 2022 Apr 21. pii: 6571576. doi: 10.1093.
    PubMed     Abstract available


  236. DAN J, da Silva Antunes R, Grifoni A, Weiskopf D, et al
    Observations and perspectives on adaptive immunity to SARS-CoV-2.
    Clin Infect Dis. 2022 Apr 20. pii: 6571103. doi: 10.1093.
    PubMed     Abstract available


  237. KIM J, Choe YJ, Jang EJ, Lim DS, et al
    Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022.
    Clin Infect Dis. 2022 Apr 19. pii: 6570782. doi: 10.1093.
    PubMed    


  238. NANISHI E, Angelidou A, Rotman C, Dowling DJ, et al
    Precision Vaccine Adjuvants for Older Adults: A Scoping Review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570880. doi: 10.1093.
    PubMed     Abstract available


  239. LEVY O, Angelidou A, Idoko O, Lewis NP, et al
    Precision Vaccines: Lessons Learned from the Coronavirus Pandemic.
    Clin Infect Dis. 2022 Apr 19. pii: 6570826. doi: 10.1093.
    PubMed    


  240. WOLDEMESKEL BA, Garliss CC, Aytenfisu TY, Johnston TS, et al
    Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient.
    Clin Infect Dis. 2022 Apr 19. pii: 6570698. doi: 10.1093.
    PubMed     Abstract available


  241. SKOWRONSKI DM, Febriani Y, Ouakki M, Setayeshgar S, et al
    Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada.
    Clin Infect Dis. 2022 Apr 19. pii: 6570607. doi: 10.1093.
    PubMed     Abstract available


  242. MAEDA H, Saito N, Igarashi A, Ishida M, et al
    Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
    Clin Infect Dis. 2022 Apr 19. pii: 6570603. doi: 10.1093.
    PubMed     Abstract available


  243. MOORE HC, Cannon JW, Kaslow DC, Lamagni T, et al
    A systematic framework for prioritising burden of disease data required for vaccine development and implementation: the case for group A streptococcal diseases.
    Clin Infect Dis. 2022 Apr 19. pii: 6570502. doi: 10.1093.
    PubMed     Abstract available


  244. PLUMMER JT, Contreras D, Zhang W, Binek A, et al
    USA SARS-CoV-2 Epsilon Variant: Though Highly Transmissible has an Adjusted Muted Host T-Cell Response.
    Clin Infect Dis. 2022 Apr 19. pii: 6570676. doi: 10.1093.
    PubMed     Abstract available


  245. LARSEN HK, Kjaer SK, Haedersdal M, Kjaer AK, et al
    Anal human papillomavirus infection in kidney transplant recipients compared with immunocompetent controls.
    Clin Infect Dis. 2022 Apr 19. pii: 6570488. doi: 10.1093.
    PubMed     Abstract available


  246. SHERMAN AC, Rouphael N, Baden LR
    COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic.
    Clin Infect Dis. 2022 Apr 18. pii: 6569988. doi: 10.1093.
    PubMed     Abstract available


  247. DALE AP, Almendares O, Howard B, Burnett E, et al
    Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021.
    Clin Infect Dis. 2022 Apr 12. pii: 6567536. doi: 10.1093.
    PubMed     Abstract available


  248. PREMIKHA M, Chiew CJ, Wei WE, Leo YS, et al
    Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore.
    Clin Infect Dis. 2022 Apr 12. pii: 6567428. doi: 10.1093.
    PubMed     Abstract available


  249. TADESSE BT, Khanam F, Ahmed F, Im J, et al
    Prevention of typhoid by Vi conjugate vaccine and achievable improvements in household WASH: Evidence from a cluster-randomized trial in Dhaka, Bangladesh.
    Clin Infect Dis. 2022 Apr 12. pii: 6567455. doi: 10.1093.
    PubMed     Abstract available


  250. RZYMSKI P, Falfushynska H, Fal A
    Vaccination of Ukrainian Refugees: Need for Urgent Action.
    Clin Infect Dis. 2022 Apr 11. pii: 6569707. doi: 10.1093.
    PubMed     Abstract available


  251. GAZIT S, Shlezinger R, Perez G, Lotan R, et al
    SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.
    Clin Infect Dis. 2022 Apr 5. pii: 6563799. doi: 10.1093.
    PubMed     Abstract available


  252. ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
    Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
    Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  253. DOLL MK, Pettigrew SM, Ma J, Verma A, et al
    Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Clin Infect Dis. 2022 Mar 24. pii: 6553950. doi: 10.1093.
    PubMed     Abstract available


  254. NG OT, Koh V, Chiew CJ, Marimuthu K, et al
    Impact of SARS-CoV-2 Vaccination and Paediatric Age on Delta Variant Household Transmission.
    Clin Infect Dis. 2022 Mar 22. pii: 6551710. doi: 10.1093.
    PubMed     Abstract available


  255. GIMENEZ E, Albert E, Zulaica J, Torres I, et al
    SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty(R) COVID-19 vaccine.
    Clin Infect Dis. 2022 Mar 21. pii: 6551700. doi: 10.1093.
    PubMed     Abstract available


  256. GALLAGHER KME, Leick MB, Larson RC, Berger TR, et al
    Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals.
    Clin Infect Dis. 2022 Mar 12. pii: 6547848. doi: 10.1093.
    PubMed     Abstract available


  257. RIFE MAGALIS B, Rich S, Tagliamonte MS, Mavian C, et al
    SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida.
    Clin Infect Dis. 2022 Mar 10. pii: 6546683. doi: 10.1093.
    PubMed     Abstract available


  258. BALCELLS ME, Le Corre N, Duran J, Ceballos ME, et al
    Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile.
    Clin Infect Dis. 2022 Mar 7. pii: 6543937. doi: 10.1093.
    PubMed     Abstract available


  259. MOORLAG SJCFM, Taks E, Ten Doesschate T, van der Vaart TW, et al
    Efficacy of Bacillus Calmette-Guerin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic.
    Clin Infect Dis. 2022 Mar 5. pii: 6543010. doi: 10.1093.
    PubMed     Abstract available


  260. POLLOCK BD, Storlie CB, Tande AJ, Sampathkumar P, et al
    Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis.
    Clin Infect Dis. 2022 Mar 5. pii: 6542971. doi: 10.1093.
    PubMed     Abstract available


  261. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population.
    Clin Infect Dis. 2022 Mar 4. pii: 6542712. doi: 10.1093.
    PubMed     Abstract available


  262. SPEICH B, Chammartin F, Abela IA, Amico P, et al
    Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial.
    Clin Infect Dis. 2022 Mar 2. pii: 6540899. doi: 10.1093.
    PubMed     Abstract available


  263. GANDHI M
    Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
    Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
    PubMed    


    February 2022
  264. BERENDSEN MLT, Silva I, Bale C, Nielsen S, et al
    The effect of a second dose of measles vaccine at 18 months of age on non-accidental deaths and hospital admissions in Guinea-Bissau: interim analysis of a randomized controlled trial.
    Clin Infect Dis. 2022 Feb 26. pii: 6537530. doi: 10.1093.
    PubMed     Abstract available


  265. HAIDAR G, Agha M, Bilderback A, Lukanski A, et al
    Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.
    Clin Infect Dis. 2022 Feb 18. pii: 6530582. doi: 10.1093.
    PubMed     Abstract available


  266. LI C, Ye Z, Zhang AJ, Chan JF, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters.
    Clin Infect Dis. 2022 Feb 18. pii: 6530400. doi: 10.1093.
    PubMed     Abstract available


  267. BECERRA-CULQUI TA, Getahun D, Chiu V, Sy LS, et al
    Prenatal influenza vaccination or influenza infection and autism spectrum disorder in offspring.
    Clin Infect Dis. 2022 Feb 17. pii: 6528744. doi: 10.1093.
    PubMed     Abstract available


  268. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels.
    Clin Infect Dis. 2022 Feb 16. pii: 6529520. doi: 10.1093.
    PubMed     Abstract available


  269. GAO DX, Fisher LD, Miller DR, Geller AC, et al
    Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study.
    Clin Infect Dis. 2022 Feb 13. pii: 6527834. doi: 10.1093.
    PubMed     Abstract available


  270. HEININGER U
    Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics.
    Clin Infect Dis. 2022;74:562-563.
    PubMed    


  271. CONTOPOULOS-IOANNIDIS DG, Altamirano J, Maldonado Y
    Infectious Diseases-Related Hospitalizations During Oral Polio Vaccine(OPV) and non-OPV immunization periods: An Empirical Evaluation of all Hospital Discharges in California(1985-2010).
    Clin Infect Dis. 2022 Feb 9. pii: 6525447. doi: 10.1093.
    PubMed     Abstract available


  272. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Real-world Effectiveness of the SARS-CoV-2 mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
    Clin Infect Dis. 2022 Feb 9. pii: 6525466. doi: 10.1093.
    PubMed     Abstract available


  273. RISK M, Shen C, Hayek SS, Holevinski L, et al
    Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant.
    Clin Infect Dis. 2022 Feb 7. pii: 6523819. doi: 10.1093.
    PubMed     Abstract available


  274. DRAWZ PE, DeSilva M, Bodurtha P, Benitez GV, et al
    Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium.
    Clin Infect Dis. 2022 Feb 7. pii: 6523820. doi: 10.1093.
    PubMed     Abstract available


  275. PERNICIARO S, van der Linden M, Weinberger DM
    Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021.
    Clin Infect Dis. 2022 Feb 7. pii: 6523816. doi: 10.1093.
    PubMed     Abstract available


  276. HELMSDAL G, Hansen OK, Moller LF, Christiansen DH, et al
    Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple-vaccinated healthcare workers.
    Clin Infect Dis. 2022 Feb 3. pii: 6520882. doi: 10.1093.
    PubMed     Abstract available


  277. ONG SWX, Sutjipto S, Lee PH, Dugan C, et al
    Validation of ISARIC 4C mortality and deterioration scores in a mixed vaccination status cohort of hospitalized COVID-19 patients in Singapore.
    Clin Infect Dis. 2022 Feb 3. pii: 6520952. doi: 10.1093.
    PubMed     Abstract available


  278. PISCHEL L, Patel KM, Goshua G, Omer SB, et al
    Adenovirus-based vaccines and thrombosis in pregnancy: A systematic review and meta-analysis.
    Clin Infect Dis. 2022 Feb 2. pii: 6520532. doi: 10.1093.
    PubMed     Abstract available


  279. NOUSHAD M, Al-Awar MS, Al-Saqqaf IS, Nassani MZ, et al
    Lack of access to COVID-19 vaccines could be a greater threat than vaccine hesitancy in low-income and conflict nations: the case of Yemen.
    Clin Infect Dis. 2022 Feb 2. pii: 6520556. doi: 10.1093.
    PubMed     Abstract available


  280. CROMER D, Reynaldi A, Steain M, Triccas JA, et al
    Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.
    Clin Infect Dis. 2022 Feb 1. pii: 6518223. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  281. HOLMDAHL I, Kahn R, Slifka KJ, Dooling K, et al
    Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants.
    Clin Infect Dis. 2022 Jan 29. pii: 6517371. doi: 10.1093.
    PubMed     Abstract available


  282. WATKINS LKF, Mitruka K, Dorough L, Bressler SS, et al
    Characteristics of Reported Deaths Among Fully Vaccinated Persons with COVID-19 -United States, January-April 2021.
    Clin Infect Dis. 2022 Jan 29. pii: 6517385. doi: 10.1093.
    PubMed     Abstract available


  283. MAERTENS K, Orije MRP, Herzog SA, Mahieu LM, et al
    Pertussis Immunization During Pregnancy: Assessment of the Role of Maternal Antibodies on Immune Responses in Term and Preterm-Born Infants.
    Clin Infect Dis. 2022;74:189-198.
    PubMed     Abstract available


  284. SPAULDING AC, Zawitz C
    Vaccination in Prisons and Jails: Corrections Needed in Future Plans.
    Clin Infect Dis. 2022 Jan 27. pii: 6515673. doi: 10.1093/cid/ciab1031.
    PubMed    


  285. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: retrospective cohort study.
    Clin Infect Dis. 2022 Jan 27. pii: 6515675. doi: 10.1093/cid/ciab1032.
    PubMed     Abstract available


  286. LAWRENZ J, Xie Q, Zech F, Weil T, et al
    SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses.
    Clin Infect Dis. 2022 Jan 25. pii: 6515378. doi: 10.1093.
    PubMed     Abstract available


  287. LIU J, Laurie MT, Rubio L, Vazquez SE, et al
    SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons.
    Clin Infect Dis. 2022 Jan 17. pii: 6509064. doi: 10.1093.
    PubMed     Abstract available


  288. MUSSI-PINHATA MM, Ward S, Laimon L, Pelton SI, et al
    Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jan 17. pii: 6509061. doi: 10.1093.
    PubMed     Abstract available


  289. SHRESTHA NK, Burke PC, Nowacki AS, Terpeluk P, et al
    Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19.
    Clin Infect Dis. 2022 Jan 13. pii: 6507165. doi: 10.1093.
    PubMed     Abstract available


  290. OLSON SM, Newhams MM, Halasa NB, Feldstein LR, et al
    Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children.
    Clin Infect Dis. 2022 Jan 13. pii: 6506316. doi: 10.1093.
    PubMed     Abstract available


  291. HEFTDAL LD, Schultz M, Lange T, Knudsen AD, et al
    Incidence of positive SARS-CoV-2 PCR after COVID-19 vaccination with up to eight months of follow-up: Real life data from the Capital Region of Denmark.
    Clin Infect Dis. 2022 Jan 7. pii: 6500168. doi: 10.1093.
    PubMed     Abstract available


  292. LI X, Chan JM, Lam B, Lung DC, et al
    COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities.
    Clin Infect Dis. 2022 Jan 4. pii: 6497432. doi: 10.1093/cid/ciab1062.
    PubMed     Abstract available


    December 2021
  293. CHOW EPF, Fairley CK, Zou H, Wigan R, et al
    Human papillomavirus antibody levels following vaccination or natural infection among young men who have sex with men.
    Clin Infect Dis. 2021 Dec 31. pii: 6491220. doi: 10.1093/cid/ciab1052.
    PubMed     Abstract available


  294. LEWNARD JA, Bruxvoort KJ, Fischer H, Hong VX, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults.
    Clin Infect Dis. 2021 Dec 30. pii: 6490150. doi: 10.1093/cid/ciab1051.
    PubMed     Abstract available


  295. YAMAMOTO S, Maeda K, Matsuda K, Tanaka A, et al
    COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study.
    Clin Infect Dis. 2021 Dec 24. pii: 6482345. doi: 10.1093/cid/ciab1048.
    PubMed     Abstract available


  296. ESSINK B, Sabharwal C, Cannon K, Frenck R, et al
    Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults 18 Years and Older.
    Clin Infect Dis. 2021 Dec 23. pii: 6481672. doi: 10.1093.
    PubMed     Abstract available


  297. DAGAN R, Van Der Beek BA, Ben-Shimol S, Pilishvili T, et al
    Corrigendum to: Effectiveness of the 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media.
    Clin Infect Dis. 2021 Dec 21. pii: 6472232. doi: 10.1093.
    PubMed    


  298. SACHDEV DD, Chew Ng R, Sankaran M, Ernst A, et al
    Contact tracing outcomes among household contacts of fully vaccinated COVID-19 patients - San Francisco, California, January 29-July 2, 2021.
    Clin Infect Dis. 2021 Dec 20. pii: 6470866. doi: 10.1093/cid/ciab1042.
    PubMed     Abstract available


  299. TYNER HL, Burgess JL, Grant L, Gaglani M, et al
    Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Dec 20. pii: 6470720. doi: 10.1093/cid/ciab1038.
    PubMed     Abstract available


  300. LUO CH, Morris CP, Sachithanandham J, Amadi A, et al
    Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
    Clin Infect Dis. 2021 Dec 18. pii: 6469786. doi: 10.1093.
    PubMed     Abstract available


  301. LU L, Mok BW, Chen LL, Chan JM, et al
    Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients.
    Clin Infect Dis. 2021 Dec 16. pii: 6463504. doi: 10.1093/cid/ciab1041.
    PubMed     Abstract available


  302. DANINO D, Ben-Shimol S, Van Der Beek BA, Givon-Lavi N, et al
    Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.
    Clin Infect Dis. 2021 Dec 14. pii: 6460745. doi: 10.1093/cid/ciab1014.
    PubMed     Abstract available


  303. SAGARA I, Zongo I, Cairns M, Yerbanga RS, et al
    The Anti-Circumsporozoite Antibody Response Of Children To Seasonal Vaccination With The Rts,S/As01e Malaria Vaccine.
    Clin Infect Dis. 2021 Dec 11. pii: 6459764. doi: 10.1093/cid/ciab1017.
    PubMed     Abstract available


  304. BART SM, Harizaj A, Pearson CL, Conteh T, et al
    SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021.
    Clin Infect Dis. 2021 Dec 10. pii: 6459157. doi: 10.1093/cid/ciab1025.
    PubMed     Abstract available


  305. KHAN K, Lustig G, Bernstein M, Archary D, et al
    Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.
    Clin Infect Dis. 2021 Dec 10. pii: 6459255. doi: 10.1093/cid/ciab1008.
    PubMed     Abstract available


  306. ROCCO JM, Mallarino-Haeger C, Randolph AH, Ray SM, et al
    Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation.
    Clin Infect Dis. 2021 Dec 10. pii: 6459155. doi: 10.1093/cid/ciab1024.
    PubMed     Abstract available


  307. FERNANDEZ-GONZALEZ M, Agullo V, Padilla S, Garcia JA, et al
    Clinical performance of a standardized SARS-CoV-2 interferon-gamma release assay for simple detection of T-cell responses after infection or vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6459152. doi: 10.1093/cid/ciab1021.
    PubMed     Abstract available


  308. HUANG YC, Sun HY, Sheng WH, Hsieh SM, et al
    Evolution of hepatitis B virus (HBV) serologic markers among antiretroviral-naive, young people living with HIV who had undergone neonatal HBV vaccination and initiated antiretroviral therapy.
    Clin Infect Dis. 2021 Dec 10. pii: 6459150. doi: 10.1093/cid/ciab1020.
    PubMed     Abstract available


  309. BUTT AA, Yan P, Shaikh OS, Mayr FB, et al
    Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population.
    Clin Infect Dis. 2021 Dec 10. pii: 6459161. doi: 10.1093/cid/ciab1023.
    PubMed     Abstract available


  310. TANG L, Cherry S, Tuomanen EI, Roubidoux EK, et al
    Host predictors of broadly cross-reactive antibodies against SARS-CoV-2 variants of concern differ between infection and vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6458694. doi: 10.1093.
    PubMed     Abstract available


  311. GANAIE F, Branche AR, Peasley M, Rosch JW, et al
    Oral streptococci expressing pneumococci-like cross-reactive capsule types can affect WHO recommended pneumococcal carriage procedure.
    Clin Infect Dis. 2021 Dec 10. pii: 6459029. doi: 10.1093/cid/ciab1003.
    PubMed     Abstract available


  312. LEWIS NM, Chung JR, Uyeki TM, Grohskopf L, et al
    Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines.
    Clin Infect Dis. 2021 Dec 7. pii: 6455504. doi: 10.1093/cid/ciab1016.
    PubMed     Abstract available


  313. HAN A, Czajkowski L, Rosas LA, Cervantes-Medina A, et al
    Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model.
    Clin Infect Dis. 2021;73:e4260-e4268.
    PubMed     Abstract available


  314. WANG W, Alvarado-Facundo E, Vassell R, Collins L, et al
    Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
    Clin Infect Dis. 2021;73:e4312-e4320.
    PubMed     Abstract available


  315. MCCONEGHY KW, Davidson HE, Canaday DH, Han L, et al
    Cluster-randomized Trial of Adjuvanted Versus Nonadjuvanted Trivalent Influenza Vaccine in 823 US Nursing Homes.
    Clin Infect Dis. 2021;73:e4237-e4243.
    PubMed     Abstract available


  316. SKOFF TH, Faulkner AE, Liang JL, Barnes M, et al
    Pertussis Infections Among Pregnant Women in the United States, 2012-2017.
    Clin Infect Dis. 2021;73:e3836-e3841.
    PubMed     Abstract available


  317. BOZIO CH, Blain A, Edge K, Farley MM, et al
    Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases-United States, 2011-2015.
    Clin Infect Dis. 2021;73:e3670-e3676.
    PubMed     Abstract available


  318. USUF E, Bottomley C, Gladstone R, Bojang E, et al
    Persistent and Emerging Pneumococcal Carriage Serotypes in a Rural Gambian Community After 10 Years of Pneumococcal Conjugate Vaccine Pressure.
    Clin Infect Dis. 2021;73:e3825-e3835.
    PubMed     Abstract available


  319. PEPPA M, Thomas SL, Minassian C, Walker JL, et al
    Seasonal Influenza Vaccination During Pregnancy and the Risk of Major Congenital Malformations in Live-born Infants: A 2010-2016 Historical Cohort Study.
    Clin Infect Dis. 2021;73:e4296-e4304.
    PubMed     Abstract available


  320. REZAHOSSEINI O, Sorensen SS, Perch M, Ekenberg C, et al
    Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation.
    Clin Infect Dis. 2021;73:e3733-e3739.
    PubMed     Abstract available


  321. SPINELLI MA, Peluso MJ, Lynch KL, Yun C, et al
    Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study.
    Clin Infect Dis. 2021 Dec 5. pii: 6453392. doi: 10.1093/cid/ciab1009.
    PubMed     Abstract available


  322. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2021 Dec 5. pii: 6453395. doi: 10.1093/cid/ciab1007.
    PubMed     Abstract available


  323. PANNUS P, Neven KY, De Craeye S, Heyndrickx L, et al
    Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naive residents of nursing homes.
    Clin Infect Dis. 2021 Dec 3. pii: 6448839. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  324. GRUNAU B, Asamoah-Boaheng M, Lavoie PM, Karim ME, et al
    A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
    Clin Infect Dis. 2021 Nov 30. pii: 6446287. doi: 10.1093.
    PubMed     Abstract available


  325. BELAY ED, Godfred Cato S, Rao AK, Abrams J, et al
    Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445178. doi: 10.1093.
    PubMed     Abstract available


  326. CHUA GT, Kwan MYW, Chui CSL, Smith RD, et al
    Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445179. doi: 10.1093.
    PubMed     Abstract available


  327. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Post-vaccination SARS-CoV-2 antibody kinetics and protection duration.
    Clin Infect Dis. 2021 Nov 27. pii: 6444809. doi: 10.1093.
    PubMed    


  328. CORREA H, Soslow JH, Dendy JM, Creech CB, et al
    Acute myopericarditis post intravenous injection of COVID-19 mRNA vaccine differs from viral myocarditis.
    Clin Infect Dis. 2021 Nov 26. pii: 6443709. doi: 10.1093.
    PubMed    


  329. LI C, Chen Y, Zhao Y, Christopher Lung D, et al
    Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
    Clin Infect Dis. 2021 Nov 25. pii: 6438764. doi: 10.1093.
    PubMed    


  330. GAZIT S, Mizrahi B, Kalkstein N, Neuberger A, et al
    BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of COVID-19 Patients.
    Clin Infect Dis. 2021 Nov 24. pii: 6437962. doi: 10.1093.
    PubMed     Abstract available


  331. STRATHDEE SA, Abramovitz D, Harvey-Vera A, Vera CF, et al
    Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
    Clin Infect Dis. 2021 Nov 22. pii: 6433374. doi: 10.1093.
    PubMed     Abstract available


  332. CANADAY DH, Oyebanji OA, Keresztesy D, Payne M, et al
    Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
    Clin Infect Dis. 2021 Nov 19. pii: 6432026. doi: 10.1093.
    PubMed     Abstract available


  333. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    PubMed     Abstract available


  334. POLLOCK L, Bennett A, Jere KC, Mandolo J, et al
    Plasma rotavirus-specific IgA and risk of rotavirus vaccine failure in infants in Malawi.
    Clin Infect Dis. 2021 Nov 12. pii: 6426173. doi: 10.1093.
    PubMed     Abstract available


  335. LIEN CE, Kuo TY, Lin YJ, Lian WC, et al
    Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Clin Infect Dis. 2021 Nov 5. pii: 6421519. doi: 10.1093.
    PubMed     Abstract available


  336. PEREZ Y, Levy ER, Joshi AY, Virk A, et al
    Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
    Clin Infect Dis. 2021 Nov 3. pii: 6420408. doi: 10.1093.
    PubMed     Abstract available


  337. SHERMAN AC, Desjardins M, Cheng CA, Bausk B, et al
    SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
    Clin Infect Dis. 2021 Nov 2. pii: 6415965. doi: 10.1093.
    PubMed     Abstract available


  338. BOSCH W, Cowart JB, Bhakta S, Carter RE, et al
    COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.
    Clin Infect Dis. 2021 Nov 2. pii: 6415962. doi: 10.1093.
    PubMed     Abstract available


  339. BRAMUGY J, Mucasse H, Massora S, Vitorino P, et al
    Short and long-term outcomes of GBS invasive disease in Mozambican children: Results of a case cohort and retrospective observational study and implications for future vaccine introduction.
    Clin Infect Dis. 2021 Nov 2. pii: 6388780. doi: 10.1093.
    PubMed     Abstract available


  340. MALVOLTI S, Pecenka C, Mantel C, Malhame M, et al
    A financial and global demand analysis to inform decisions for funding and clinical development of GBS vaccines for pregnant women.
    Clin Infect Dis. 2021 Nov 2. pii: 6412619. doi: 10.1093.
    PubMed     Abstract available


  341. BROWN NE, Blain AE, Burzlaff K, Harrison LH, et al
    Racial Disparities in Invasive Haemophilus influenzae Disease-United States, 2008-2017.
    Clin Infect Dis. 2021;73:1617-1624.
    PubMed     Abstract available


  342. BERENSON AB, Hirth JM, Chang M
    Prevalence of Genital Human Papillomavirus by Age and Race/Ethnicity Among Males.
    Clin Infect Dis. 2021;73:1625-1633.
    PubMed     Abstract available


  343. MIELLET WR, van Veldhuizen J, Nicolaie MA, Mariman R, et al
    Influenza-like Illness Exacerbates Pneumococcal Carriage in Older Adults.
    Clin Infect Dis. 2021;73:e2680-e2689.
    PubMed     Abstract available


  344. THOMPSON RR, Kong CL, Porco TC, Kim E, et al
    Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.
    Clin Infect Dis. 2021;73:e3210-e3217.
    PubMed     Abstract available


  345. ISHIKAWA T, Okai M, Mochizuki E, Uchiyama T, et al
    Bacillus Calmette-Guerin (BCG) Infections at High Frequency in Both AR-CGD and X-CGD Patients Following BCG Vaccination.
    Clin Infect Dis. 2021;73:e2538-e2544.
    PubMed     Abstract available


  346. TESSIER E, Campbell H, Ribeiro S, Fry NK, et al
    Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014-2018.
    Clin Infect Dis. 2021;73:e2502-e2508.
    PubMed     Abstract available


  347. LEE JH, Lee YB, Cho EJ, Yu SJ, et al
    Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study.
    Clin Infect Dis. 2021;73:e3308-e3316.
    PubMed     Abstract available


    October 2021
  348. MARSHALL GS, Ghaswalla PK, Bengtson LGS, Buikema AR, et al
    Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States.
    Clin Infect Dis. 2021 Oct 28. pii: 6413775. doi: 10.1093.
    PubMed     Abstract available


  349. WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
    Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
    Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
    PubMed     Abstract available


  350. THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
    Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Clin Infect Dis. 2021 Oct 26. pii: 6410706. doi: 10.1093.
    PubMed    


  351. MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
    Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
    Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
    PubMed     Abstract available


  352. WOLDEMESKEL BA, Garliss CC, Blankson JN
    mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
    Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
    PubMed     Abstract available


  353. WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
    Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
    Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
    PubMed     Abstract available


  354. BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
    Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords.
    Clin Infect Dis. 2021 Oct 20. pii: 6398590. doi: 10.1093.
    PubMed     Abstract available


  355. ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
    Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
    Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
    PubMed     Abstract available


  356. ISTURIZ R, Grant L, Gray S, Alexander-Parrish R, et al
    Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.
    Clin Infect Dis. 2021;73:1216-1222.
    PubMed     Abstract available


  357. LADHANI SN, Campbell H, Andrews N, Parikh SR, et al
    First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England.
    Clin Infect Dis. 2021;73:e1661-e1668.
    PubMed     Abstract available


  358. MARSHALL HS, Maiden MCJ
    Impact of a Meningococcal Protein-based Serogroup B Vaccine on Serogroup W Invasive Disease in Children.
    Clin Infect Dis. 2021;73:e1669-e1672.
    PubMed    


  359. HUANG W, Chiu NC, Chi H, Huang FY, et al
    Inoculation Age of Bacillus Calmette-Guerin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
    Clin Infect Dis. 2021;73:e1554-e1559.
    PubMed     Abstract available


  360. MARIN M, Fiebelkorn AP, Bi D, Coleman LA, et al
    Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.
    Clin Infect Dis. 2021;73:e1546-e1553.
    PubMed     Abstract available


  361. HURLEY D, Griffin C, Young M, Scott DA, et al
    Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
    Clin Infect Dis. 2021;73:e1489-e1497.
    PubMed     Abstract available


  362. RIVERA L, Biswal S, Saez-Llorens X, Reynales H, et al
    Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003).
    Clin Infect Dis. 2021 Oct 4. pii: 6381105. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  363. LUNDBO LF, Harboe ZB, Sandholdt H, Smith-Hansen L, et al
    Comorbidity increases the risk of invasive meningococcal disease in adults.
    Clin Infect Dis. 2021 Sep 27. pii: 6375918. doi: 10.1093.
    PubMed     Abstract available


  364. MAZUR NI, Lowensteyn YN, Willemsen JE, Gill CJ, et al
    Global Respiratory Syncytial Virus-Related Infant Community Deaths.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  365. SRIKANTIAH P, Vora P, Klugman KP
    Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  366. SNYMAN J, Hwa SH, Krause R, Muema D, et al
    Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave.
    Clin Infect Dis. 2021 Sep 2. pii: 6362722. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  367. DAWOOD FS, Varner M, Tita A, Newes-Adeyi G, et al
    Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States.
    Clin Infect Dis. 2021 Aug 19. pii: 6354856. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  368. KOELMAN DLH, Brouwer MC, Ter Horst L, Bijlsma MW, et al
    Pneumococcal meningitis in adults: a prospective nationwide cohort studY over a 20-year period.
    Clin Infect Dis. 2021 May 24. pii: 6283697. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  369. DEGRAZIA D, Miller FG
    SARS-CoV-2 Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective.
    Clin Infect Dis. 2021 Mar 31. pii: 6205379. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  370. DAGAN R, Ben-Shimol S, Benisty R, Regev-Yochay G, et al
    A Nationwide Outbreak of Invasive Pneumococcal Disease in Israel Caused by Streptococcus Pneumoniae Serotype 2.
    Clin Infect Dis. 2020 Nov 17. pii: 5983781. doi: 10.1093/cid/ciaa1720.
    PubMed     Abstract available


    September 2020
  371. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    PubMed     Abstract available


    July 2020
  372. HUANG H, Xu C, Liu L, Chen L, et al
    Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus.
    Clin Infect Dis. 2020 Jul 8. pii: 5868509. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  373. KANSAGRA K, Parmar D, Mendiratta SK, Patel J, et al
    A Phase 3, Randomised, Open-Label, Non-inferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG).
    Clin Infect Dis. 2020 Jun 17. pii: 5858415. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.